Screener
Castle Biosciences CSTL Business Segments — Personnel costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept cstl:PersonnelCosts.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Net revenues from external customers(1) | $83,679 | $87,988 |
| Significant segment expenses: | ||
| Personnel costs | 58,367 | 52,200 |
| Organizational and marketing costs | 15,594 | 14,229 |
| Inventory usage | 6,437 | 4,731 |
| Clinical studies and publication costs | 2,542 | 2,085 |
| Professional services | 3,007 | 3,576 |
| Other segment items | 12,254 | 37,015 |
Item 1. Financial Statements.
FAQ
- What is Castle Biosciences's business segments — personnel costs?
- Castle Biosciences (CSTL) reported business segments — personnel costs of $58.37M in Q1 2026.
- How has Castle Biosciences's business segments — personnel costs changed year-over-year?
- Castle Biosciences's business segments — personnel costs increased by 11.8% year-over-year, from $52.2M to $58.37M.
- What is the long-term trend for Castle Biosciences's business segments — personnel costs?
- Over 3 years (2022 to 2025), Castle Biosciences's business segments — personnel costs has grown at a 16.0% compound annual growth rate (CAGR), from $134.56M to $209.82M.
- What does business segments — personnel costs mean?
- Includes all compensation-related expenses for employees within the reportable segment, such as salaries, bonuses, and benefits. Monitoring this helps evaluate the scalability of the workforce relative to revenue growth and operational output.
Ask your AI about Castle Biosciences's business segments — personnel costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude